Expression of the Bacillus subtilis dra-nupC-pdp operon is subject to catabolite repression by glucose. It was shown that a cis-acting catabolite-responsive element (CRE) sequence located 64 bp downstream of the transcription-start site mediated catabolite repression of the dra-nupC-pdp operon as it does for many other B. subtilis genes. Point mutations in the CRE sequence caused the loss of catabolite repression of the operon. Catabolite repression of dra-nupC-pdp expression was relieved in a ccpA mutant and was found to be dependent on both HPr and the HPr-like protein Crh. Furthermore, a transcription-repair coupling factor, Mfd, was also found to be involved in the glucose repression of dra-nupC-pdp expression. By the use of in vitro gel mobility shift analysis, a specific HPr-P dependent binding of CcpA to the dra CRE site was demonstrated.
INTRODUCTION
Catabolite repression is a general regulatory mechanism of gene expression in response to the availability of carbohydrates in the growth medium. In the presence of a rapidly metabolized carbon source, the synthesis of enzymes involved in the utilization of other carbohydrates is inhibited.
Recent publications present evidence that catabolite repression in Bacillus subtilis involves transcriptional repression mediated by a negative-control system (Hueck & Hillen, 1995 ; Saier et al., 1996) . Three components are found to be involved in this process : a cis-acting sequence called the catabolite-responsive element (CRE), a trans-acting factor called catabolite control protein A (CcpA), which is a member of the LacI-GalR family of transcription regulatory proteins, and a second trans-acting factor HPr, which is a component of the phosphoenolpyruvate-carbohydrate phosphotransferase system. The HPr protein of B. subtilis can be phosphorylated at two sites : one at His-15 by enzyme I of the phosphotransferase system and the other at Ser-46 by an ATP-dependent protein kinase. ptsH1 mutation, which changes the Ser-46 residue of HPr to alanine and thereby prevents phosphorylation of the protein by the ATP-dependent protein kinase, has been reported for several catabolite-repressed genes (Deutscher et al., 1994 ; Kruger et al., 1996 ; MartinVerstraete et al., 1995) . A homologue of HPr encoded by the crh gene has been reported also to be involved in catabolite repression of inositol dehydrogenase, levanase and β-xylosidase expression (Galinier et al., 1997) . The seryl-phosphorylated Crh protein has a similar function to P-Ser-HPr ; it induces the binding of CcpA to CRE sequences Galinier et al., 1999) .
It is suggested that catabolite repression of target genes in Gram-positive bacteria is achieved by the following mechanism : the metabolite-activated HPr(ser) kinase phosphorylates Ser-46 in HPr, converting it to a form that can bind to the transcription factor, CcpA. These two proteins, probably together with a metabolite such as fructose 1,6-bisphosphate, form a complex, which binds to CREs of catabolite-sensitive target genes to promote catabolite repression (Deutscher et al., 1995 ; Fujita et al., 1995) . But the finding of P-Ser-HPr independent binding of CcpA complexed with glucose 6-phosphate leads to the proposal that P-Ser-HPr triggers non-cooperative binding of CcpA to CRE sequences, whereas glucose 6-phosphate activates cooperative binding of CcpA to CRE sequences (Fujita et Go$ sseringer et al., 1997 ; Miwa et al., 1997 ; Zalieckas et al., 1998b) . However, cofactorindependent sequence-specific DNA binding by CcpA has also been reported (Kim et al., 1995) .
Recently, in B. subtilis, several other factors such as CcpB (Chauvaux et al., 1998 ), CcpC (Jourlin-Castelli et al., 2000 , Crh (Galinier et al., 1997) , and a transcriptionrepair coupling factor, Mfd (Zalieckas et al., 1998b) , have been reported to be involved in catabolite repression. CcpB, which exhibits 30 % sequence identity to CcpA, is found to mediate catabolite repression of gnt and xyl in cells grown on solid medium or in liquid medium with little agitation (Chauvaux et al., 1998) . CcpC, which belongs to the LysR family of transcriptional regulators was found to participate in carbon repression of citB (Jourlin-Castelli et al., 2000) . Crh, which exhibits 45 % sequence identity to HPr, is not phosphorylated by phosphoenolpyruvate and enzyme I, but is phosphorylated by ATP and the HPr kinase at Ser-46 and it is required for catabolite repression of certain catabolite operons (Galinier et al., 1997) . The Mfd protein, encoded by mfd, is known to promote strandspecific DNA repair by displacing RNA polymerase stalled at a nucleotide lesion and directing the (A)BC excinuclease to the DNA damage site. Resistance towards glucose repression in an mfd mutant has been reported for catabolite-repressed genes containing the CRE sequence located downstream of the transcriptionstart site (Zalieckas et al., 1998b) . A model for how catabolite repression is relieved in an mfd mutant was proposed by Zalieckas et al. (1998b) . The Mfd protein is proposed to displace RNA polymerase stalled at downstream CRE sites that function as transcription road blocks. The mfd mutation relieves catabolite repression of hut and gnt expression at the CRE sequences located downstream of the transcriptional start sites, but does not affect catabolite repressiom at sites located at the promoters (Zalieckas et al., 1998b) .
In B. subtilis, three enzymes required for the utilization of deoxyribonucleosides as carbon sources are encoded within an operon, dra-nupC-pdp (Saxild et al., 1996) . The expression of the operon is induced by deoxyribonucleosides and deoxyribose (Saxild et al., 1996 ; Zeng & Saxild, 1999) . Transcription of this operon is negatively regulated by the DeoR repressor protein encoded by the gene deoR (Saxild et al., 1996) . The operator for DeoR contains a palindromic sequence and a direct repeat sequence to the 3h half of the palindrome located from k58 to k20 bp relative to the transcription-start point (Zeng & Saxild, 1999) . The metabolite deoxyribose 5-phosphate is suggested to be the internal inducer for the expression of the operon (Zeng & Saxild, 1999 ; Zeng et al., 2000) .
Expression of the dra-nupC-pdp operon is repressed by glucose. A CRE sequence located in the start of dra was found to be involved in catabolite repression of the operon (Zeng & Saxild, 1999) . In this study, we show that CcpA-mediated catabolite repression of the operon works via this downstream CRE sequence and that HPr, Crh and Mfd participate in catabolite control of dra-nupC-pdp operon expression.
METHODS
Bacterial strains, plasmids and media. The bacterial strains and plasmids used in this work are listed in Table 1 . B. subtilis was grown in Spizizen minimal salts medium (Saxild et al., 1996) supplemented with 50 µg -tryptophan ml − " and with either 0n4 % glucose or 0n4 % succinate as the carbon source. L broth (Difco) was used as a rich medium for both Escherichia coli and B. subtilis. Culturing of cells was performed at 37 mC. For selection of antibiotic resistance, antibiotics were used at the following final concentrations : ampicillin, 100 µg ml − " ; chloramphenicol, 6 µg ml − " ; neomycin, 5 µg ml − " ; erythromycin, 1 µg ml − " ; lincomycin, 25 µg ml − " ; spectinomycin, 100 µg ml − ".
DNA manipulations and genetic techniques. B. subtilis chromosomal DNA and plasmid DNA was isolated as described previously (Saxild et al., 1996) . Transformation of E. coli and B. subtilis was performed as previously described (Saxild et al., 1996) . Treatment of DNA with restriction enzymes and T4 DNA ligase was performed as recommended by the supplier. DNA sequences were obtained using the Amersham Pharmacia Biotech Thermo Sequenase radiolabelled termination cycle sequencing kit. All sequencing analysis was done on double-stranded plasmid or PCR product DNA templates and performed as described by the supplier. Standard PCR reactions were performed as described previously (Zeng & Saxild, 1999) .
Construction of dra-lacZ fusions. Different deletion derivatives of the dra control region were amplified by PCR using plasmid pHH1011, which contains the 3h end of deoR and the 5h end of dra, as template DNA (Zeng & Saxild, 1999) . The forward and reverse oligonucleotide primers were synthesized with an EcoRI and BamHI 5h-linked restriction site, respectively ( Table 2 ). The various dra DNA fragments used for the construction of dra-lacZ fusions were amplified with primer 2 together with one of the primers 1, 3, 6, 7 or 4. The PCR products were digested with EcoRI\BamHI, ligated to EcoRI\BamHI-digested plasmid pDG268erm or pDG268neo and transformed into E. coli MC1061 selecting for ampicillin resistance. Plasmids extracted from E. coli (pJOY512, pJOY5156erm, pJOY5156neo, pJOY5157, pJOY5158 and pJOY5161 ; Table 1 ) were linearized by KpnI and recombined into the amyE locus of B. subtilis 168 by transformation and selection for neomycin resistance. The correct integration into the amyE locus was confirmed by the amylase-negative phenotype of the transformants. The resulting B. subtilis strains were XM512, XM5156erm, XM5156neo, XM5157, XM5158 and XM5161 (Table 1) .
Construction of P Spac -lacZ fusions. Two 71 bp PCR products amplified by primers 5j3 and 5j6, containing the dra ribosome-binding site and either wild-type or mutant CRE sequence of dra, were cloned in the EcoRI and BamHI sites of pMutin4. The resulting plasmids, pMutin7756 and pMutin7757, were transformed into E. coli MC1061 selecting for ampicillin resistance. Plasmids extracted from E. coli were transformed into XM268 (which contains a promoterless lacZ gene integrated in the amyE locus) by a single crossover between the two copies of lacZ following selection for erythromycin resistance. The correct integration into the lacZ 
Deletion analysis
* Underlined letters indicate the position of the restriction site sequence. Bold letters indicate nucleotides that differ from the wild-type sequence. † The number indicates the position of the 5h proximal nucleotide of the primer relative to the dra transcription-start site (Zeng & Saxild, 1999) . The transcription-start point is genome nucleotide number 4051089 (Kunst et al., 1997) .
gene located at the amyE locus of XM268 was confirmed by direct DNA sequencing of specific PCR products from the transformants covering the flanking regions of the lacZ gene. The resulting B. subtilis strains were XM2681 and XM2683 (Table 1) .
Site-directed mutagenesis. This was performed by using oligonucleotides with a single mismatch as PCR primers. The primer sequences are shown in Table 2 . A standard PCR reaction was performed with one of these primers together with primer 2. The resulting 122 bp PCR products were cloned into pDG268neo and transformed into B. subtilis as described above. The resulting strains are listed in Table 1 .
β-Galactosidase assay. β-Galactosidase activity was measured according to the method of Miller (1972) . Specific enzyme activities are expressed as U (mg protein) − ". One unit is defined as 1 nmol substrate converted min − ". The presented values are means of at least three different experiments. The variation was less than 15 %. Total protein concentration was determined by the Lowry method.
Mobility-shift assay. The standard PCR mixture containing 25 µmol [α-$$P]dATP (25 µCi) was used to produce the radiolabelled operator-containing DNA probes. The 148 bp labelled fragments were generated by combining primers 8j3 and 9j3. Each binding reaction mixture contained 10 mM Tris\HCl, 50 mM NaCl, 1 mM EDTA, 1 mM DTT (pH 7n5), 1 U ml − " double-stranded poly(dI-dC), 250 µg BSA ml − " and 5% (v\v) glycerol in a final volume of 10 µl. Approximately 10-100 pM labelled DNA probe and various concentrations of proteins were used in each binding reaction. After incubation for 20 min at room temperature, samples were loaded onto a 5 % polyacrylamide gel and electrophoresed at 7 V cm − " for 1 h. Dried gels were visualized with a Packard Instant Imager. CcpA and HPr proteins were both purified on Ni-nitrilotriacetate-agarose columns (Galinier et al., 1998) . HPr was phosphorylated by HprK in the presence of ATP as described by Galinier et al. (1998) .
RESULTS

Localization of the dra-nupC-pdp CRE site using deletion analysis and site-directed mutagenesis
A set of dra-lacZ transcriptional fusions was constructed for deletion analysis of the catabolite control region of the dra-nupC-pdp operon. These fusions were introduced into the amyE locus on the chromosome in a single copy as described in Methods. The upstream end point of all the fusions was at position k40 relative to the transcription-start site and therefore the fusions do not include the DeoR operator (O deoR ) site. The positions of the downstream end points were different and are given in Table 3 . Catabolite repression of these fusions was monitored during growth in media containing either glucose or succinate as the carbon source (Table 3) . The β-galactosidase activity in strains containing a dra-lacZ fusion including the potential CRE sequence (XM512 and XM5156neo) was repressed approximately fivefold in glucose-grown cells compared to succinate-grown cells, whereas no glucose repression was observed in strains containing a dra-lacZ fusion not including the CRE sequence (XM5161). Point mutations were introduced into the CRE sequence by site-directed mutagenesis. Two mutant strains, XM5157 and XM5158, each having a single-base-pair mutation in the central conserved C or G residue of the CRE sequence, were constructed and β-galactosidase activity was assayed after growth in minimal media with either glucose or succinate as the carbon source. The introduction of a point mutation in strains XM5157 and XM5158 reduced the level of regulation to only 1n2-and 1n4-fold, respectively. This should be compared to the 5n4-fold repression in the comparable wild-type strain * Mut indicates that the CRE element contains either the cre57 or cre58 point mutation described in Methods. † nmol min −" (mg protein) −" . ‡ Numbers in parentheses indicate level (fold) of repression and were calculated by dividing the enzyme activity in succinate-grown cells by the enzyme activity in glucose-grown cells.
XM5156neo. These results indicated that catabolite repression of dra-nupC-pdp expression is mediated by the CRE sequence located at position j64. Inspection of the nucleotide sequence and additional deletion analysis revealed no other potential CRE elements in the region from position k80 to j154 (data not shown). We therefore conclude that the B. subtilis dra-nupCpdp operon most likely carries a single cis-acting CRE sequence at position j64 relative to the transcriptionstart site.
To investigate whether DeoR affected catabolite repression control at the dra CRE site a lacZ fusion including O deoR was constructed (XM15). It was observed that dra expression was not totally repressed during growth on glucose in the absence of deoxyribose. The level of 20-30 U (mg protein) −" of β-galactosidase activity seen in non-induced strains growing on glucose is significantly higher than in a wild-type strain containing no dra-lacZ fusion [approximately 1 U (mg protein) −" (data not shown)]. In the absence of inducer, that is when the fusion is repressed by DeoR, it appears that there is no catabolite control of dra expression (XM15 , Table 3 ). One explanation for this phenomenon could be that some minimum number of transcription complexes arriving at the CRE site is required for catabolite repression to operate. This hypothesis was tested using two transcriptional fusions between the IPTG-inducible promoter, P spac , and lacZ. These fusions, which contain neither the dra promoter nor O deoR , are composed of a 71 bp fragment containing the wild-type or mutant CRE sequence of dra inserted between the P spac promoter and lacZ, respectively (see Methods). Expression of β-galactosidase from these fusions as regulated by catabolite repression was monitored during growth in media containing either glucose or succinate as the carbon source. We found that catabolite repression was observed at all levels of IPTG tested up to 1 mM in the fusion strain containing the wild-type CRE, whereas no repression was observed in the fusion strain carrying the mutant CRE (data not shown). This indicated that catabolite control was turned on even at very low transcription-initiation frequencies and did not require some minimum amount of transcription dosage for normal function.
Role of CcpA and the effect of the ptsH1, crh and mfd mutations on dra-nupC-pdp expression A ccpA gene-disruption mutation was introduced into strains XM5156neo and XM5161. XM5156neo and XM5161 carry a transcriptional dra-lacZ fusion with or without CRE, respectively. β-Galactosidase activity was measured for the ccpA derivatives XM5156A and XM5161A grown either in glucose or succinate (Table  3) . It was shown that glucose repression was almost completely relieved in a ccpA genetic background containing a dra-lacZ fusion either with or without the CRE sequence. The level in succinate-grown cells was unchanged while the level in glucose was increased compared to the wild-type derivatives grown under the same conditions. Essentially the same effect was observed when the cre58 allele was substituted for ∆cre in the ccpA genetic background (XM5158A). To test whether the glucose catabolite repressor protein CcpA in some way affected the observed constitutively low level of dra expression in the absence of the inducer deoxyribose (see previous paragraph), a ccpA derivative of XM15 (containing the dra-lacZ fusion including the O DeoR sequence) was constructed (XM45) and analysed for dra expression during growth with glucose or succinate. The dra expression level in strain XM45 during growth on glucose, in the absence of deoxyribose, was similar to that of the wild-type, which means that the low level of dra expression is not a result of the action of CcpA. On the other hand, in the presence of inducer, high constitutive levels were found in both glucose-and succinate-grown cells, indicating that CcpA is involved in catabolite control of dra expression, at least under induced conditions. All the results presented above indicate that CcpA is responsible for the glucose control of the dra-nupC-pdp operon expression.
To study whether HPr and Crh play a role in catabolite repression of the dra-nupC-pdp operon, a ptsH1 mutation was introduced into strain XM5156erm carrying a transcriptional dra-lacZ fusion, resulting in strain XM5156P. Similarly, a crh gene disruption mutation (Galinier et al., 1997) was introduced into XM5156erm resulting in XM5156C. The β-galactosidase activity of both glucose-and succinate-grown cells was measured for these two strains (Table 3) . Glucose repression was partially relieved resulting in a reduction to 1n9-fold of regulation in the ptsH1 mutant, while disruption of the crh gene in the wild-type background did not alter the pattern of catabolite repression of the operon expression. However, disruption of the crh gene in the ptsH1 background (XM5156PC) almost totally abolished catabolite repression. These results suggested that, in addition to HPr, which plays the major role in signalling the presence of glucose to CcpA, Crh also participated in catabolite repression of the dra-nupC-pdp operon as it does for other B. subtilis catabolite-repressed genes such as lev and xyn Galinier et al., 1999) . To investigate the role of Mfd in catabolite repression of dra-nupC-pdp operon expression, an mfd : :Tn10 mutation was introduced into XM5156erm resulting in strain XM5156M, and β-galactosidase activity was measured in both glucose-and succinategrown cells (Table 3 ). The results showed that the glucose repression was only 2n5-fold in the mfd mutant compared to 5n4-fold in the wild-type cells. This result CcpA (µM) HPr-P (µM) Fig. 1 . Binding of CcpA to the CRE of the dra-nupC-pdp operon. A profile of a mobility-shift assay is shown. DNA fragments containing either the wild-type cre (lanes 1-3) or the mutant cre57 element (lanes 4-6) were incubated with various combinations of CcpA and P-Ser-HPr.
was similar to what has been observed for the expression of the hut and gnt operons in an mfd genetic background (Zalieckas et al., 1998b) . So CcpA most likely mediates catabolite repression of dra expression via the binding to a single downstream CRE, thus functioning by a transcriptional road-block mechanism.
Specific interaction between CcpA and CRE
The presumed interaction between CcpA and the CRE of the dra-nupC-pdp operon was demonstrated by an in vitro gel mobility-shift experiment. The DNA probes were two [$$P]-labelled 148 bp fragments containing either the wild-type CRE sequence or the mutant CRE sequence with an A substituted for the central C (cre57).
As shown in Fig. 1 , the mobility of the labelled DNA containing the wild-type CRE was shifted in the presence of CcpA and P-Ser-HPr, but no shift was observed for the DNA with the mutant CRE. When CcpA was present alone in the assay, no interaction was observed (Fig. 1, lane 2) ; only in the presence of P-Ser-HPr did CcpA specifically recognize the CRE (Fig. 1, lane 3) . The results presented in Fig. 1 clearly demonstrate the specific P-Ser-HPr dependent binding of CcpA to the dra CRE site. The results complement the previous genetic data obtained using lacZ fusions and various regulatory mutations (Table 3) .
DISCUSSION
By the use of both genetic and biochemical means we have demonstrated that the B. subtilis dra-nupC-pdp operon carries a downstream CRE sequence that is involved in CcpA-mediated catabolite repression. Moreover, HPr, Crh and Mfd were proved to participate in catabolite repression of the operon expression. The pattern of catabolite repression of the dra-nupC-pdp operon provides us with a fine example in which all the factors found to be involved in the negative-control system of catabolite repression in B. subtilis play a role in catabolite control of this operon. An interesting aspect of our study is that catabolite repression of the dra-nupC-pdp operon is absent when the expression is repressed by the DeoR repressor. Only in a deoR strain or in a wild-type strain induced with deoxyribose (Zeng & Saxild, 1999) does catabolite
